
Monovalent Rotavirus Vaccine Effectiveness Against Rotavirus Hospitalizations Among Children in Zimbabwe
Author(s) -
Hilda Mujuru,
Eleanor Burnett,
Kusum Nathoo,
Ismail Ticklay,
Nhamo A Gonah,
Arnold Mukaratirwa,
Chipo Berejena,
Portia Manangazira,
Maxwell Rupfutse,
Goitom Weldegebriel,
Jason M. Mwenda,
Catherine Yen,
Umesh D. Parashar,
Jacqueline E. Tate
Publication year - 2018
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy1096
Subject(s) - medicine , rotavirus , rotavirus vaccine , diarrhea , vaccination , pediatrics , odds ratio , confidence interval , immunology
Rotavirus is a leading cause of mortality among children <5 years old. We evaluated monovalent rotavirus vaccine effectiveness (VE) under conditions of routine use at 2 surveillance sites in Harare, Zimbabwe, after vaccine introduction in May 2014.